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Male germ cell DNA damage, after exposure to radiation,
exogenous chemicals, or chemotherapeutic agents, is a major
cause of male infertility. DNA-damaged spermatozoa can fertilize
oocytes; this is of concern because there is limited information on
the capacity of early embryos to repair a damaged male genome or
on the fate of these embryos if repair is inadequate. We
hypothesized that the early activation of DNA damage response
in the early embryo is a critical determinant of its fate. The
objective of this study was to assess the DNA damage response
and mitochondrial function as a measure of the energy supply for
DNA repair and general health in cleavage-stage embryos sired by
males chronically exposed to an anticancer alkylating agent,
cyclophosphamide. Male rats were treated with saline or
cyclophosphamide (6 mg/kg/day) for 4 weeks and mated to
naturally cycling females. Pronuclear two- and eight-cell embryos
were collected for immunoﬂuorescence analysis of mitochondrial
function and biomarkers of the DNA damage response: gH2AX
foci, 53BP1 reactivity, and poly(ADP-ribose) polymer formation.
Mitochondrial activities did not differ between embryos sired by
control- and cyclophosphamide-exposed males. At the two-cell
stage, there was no treatment-related increase in DNA double-
strand breaks; by the eight-cell stage, a signiﬁcant increase was
noted, as indicated by increased medium and large gH2AX foci.
This was accompanied by a dampened DNA repair response,
detected as a decrease in the nuclear intensity of poly(ADP-ribose)
polymers. The micronuclei formed in cyclophosphamide-sired
embryos contained large gH2AX foci and enhanced poly(ADP-
ribose) polymer and 53BP1 reactivity compared with their nuclear
counterparts. Thus, paternal cyclophosphamide exposure acti-
vated a DNA damage response in cleavage-stage embryos.
Furthermore, this damage response may be useful in assessing
embryo quality and developmental competence.
Key Words: cyclophosphamide; gH2AX; 53BP1; poly(ADP-
ribose) polymers; spermatozoa; embryo; epigenetic marks.
Millions of men of reproductive age now survive cancer as
a consequence of improvements in cancer treatment regimens
consisting of chemotherapeutic agents and/or radiation (Green
et al., 2010). However, fertility is of concern to many of these
men because these treatment regimens usually lead to an initial
drop in sperm production that may be sustained for months to
years, causing infertility in a large proportion of subjects
(Green et al., 2010). Even men who recover spermatogenesis
may still be infertile and may be faced with the possibility of
transmitting heritable genetic diseases to their offspring.
Cyclophosphamide, a nitrogen mustard compound, is com-
monly used as a cancer therapeutic and immunosuppressant
agent. This drug is a bifunctional alkylating agent, forming
DNA adducts, DNA cross-links, and single and double-strand
DNA breaks in dividing cells. The exposure of male rats to
cyclophosphamide induces DNA damage in spermatozoa that
ranges from DNA double-strand breaks (DSBs) and single-
strand breaks to chromosomal aberrations (Barton et al., 2003;
Codrington et al., 2004). Furthermore, this paternal cyclophos-
phamide treatment results in dose-dependent and time-speciﬁc
effects on progeny outcome, including pre- and postimplanta-
tion loss, malformations, and deﬁcits in learning behavior;
some of these outcomes are observed in subsequent generations
(Auroux et al., 1990; Hales et al., 1992; Trasler et al., 1986).
Our labs, and others, have used cyclophosphamide to elucidate
the mechanisms underlying male-mediated developmental
toxicity (Barton et al., 2007; Grenier et al., 2011).
The male genome is tightly packaged for delivery to the
oocyte (Ward, 2010); paternal drug exposures may disturb the
packaging of male germ cell chromatin. Indeed, paternal
cyclophosphamide treatment alters the sperm basic proteome,
and speciﬁcally, some components of the nuclear matrix that
may be involved in events during spermiogenesis and
fertilization (Codrington et al., 2007a,b). The timing of
spermatozoal decondensation and the deposition of modiﬁed
histones are accelerated in zygotes fertilized by spermatozoa
from cyclophosphamide-treated males (Grenier et al., 2010). In
pronuclear-stage embryos sired by drug-treated males, the
epigenetic programming of both parental genomes is disrupted,
as manifested by changes in the regulation of histone H4
acetylation at lysine 5 and in DNA methylation (Barton et al.,
2005). The incidence of micronuclei is dramatically elevated in
two-cell embryos fertilized by spermatozoa from cyclophos-
phamide-treated fathers; moreover, the presence of these
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et al., 2011) and is reﬂected by the proportion of peri-
implantation embryonic loss observed in previous studies
(Trasler et al., 1986). Together, these ﬁndings demonstrate that
paternal exposure to cyclophosphamide damages the male
genome and disrupts postfertilization events in the early
embryo.
Functional mitochondria are crucial for fertilization and
determine the developmental potential of early embryos. Stage-
speciﬁc changes in the functional compartmentalization of
mitochondria are required to meet the energy needs of embryos
throughout preimplantation development (van Blerkom, 2011).
Furthermore, the activation and maintenance of DNA damage
responses require the energy produced by mitochondria.
There are multiple DNA damage and repair pathways in
cells. DNA damage, in the form of DSBs, is detected by the
rapid phosphorylation of histone H2AX at serine 139
(Rogakou et al., 1998). Small cH2AX foci are associated with
cell-cycle regulation and mitosis, medium foci (0.30–9.99 lm
3)
act as repair platforms, recruiting DNA repair proteins to sites
of damage, and large foci are indicative of DNA damage
accumulation and DNA DSB aggregates (McManus and
Hendzel, 2005; Paull et al., 2000). cH2AX foci are induced
in the male pronuclei of zygotes sired by cyclophosphamide-
treated male rats (Barton et al., 2007; Grenier et al., 2010).
Large cH2AX foci colocalize with DNA DSB repair
proteins (McManus and Hendzel, 2005), including p53-binding
protein 1 (53BP1) and poly(ADP-ribose) polymerase-1
(PARP-1) (Paull et al., 2000). 53BP1, a component of the
nonhomologous end joining repair pathway, is involved in
DNA damage–induced cell cycle arrest and participates in
DNA repair (Wang et al., 2002; Ward et al., 2003). In somatic
cells, 53BP1 displays both cytoplasmic and nuclear local-
izations (Iwabuchi et al., 1998). Inhibition of the nuclear
importation of 53BP1 decreases ionizing radiation-induced
53BP1 focus formation, delays DNA repair, and impairs cell
survival (Moudry et al., 2011). In the early mouse zygote,
53BP1 is present only in the cytoplasm, whereas by the late
pronuclear stage, some staining is found in the pronuclei
(Ziegler-Birling et al., 2009). In the two- and eight-cell stages,
staining is enriched in the nuclei, but no particular association
is observed with any nuclear structure.
Poly(ADP-ribose) (PAR) polymerase-1 (PARP-1) is acti-
vated by DNA single-strand breaks and at stalled replication
forks to facilitate DNA repair. In response to DNA damage,
PARP-1 catalyzes the formation of poly(ADP-ribose) (PAR)
polymers, with nicotinamide adenine dinucleotide (NADH) as
an energy cofactor, covalently modifying acceptor structural
chromatin proteins (Schreiber et al., 2006) and decondensing
the chromatin to allow access of other repair factors to sites of
DNA damage (Zhou et al., 2010). The removal of PAR
polymers is primarily catalyzed by PAR glycohydrolase
(PARG) (Brochu et al., 1994). The metabolism of PAR is
important during chromatin dynamics, DNA replication, and
repair (D’Amours et al., 1999; Kim et al., 2004). The proper
regulation of PARP-1 is critical for the maintenance of
genomic stability (Schreiber et al., 2006) because PARP-1
functions as a DNA repair protein in response to single-strand
breaks, in the base excision repair pathway (Dantzer et al.,
1999), and in the induction of cell death in response to
genotoxic stress (Yu et al., 2002). Interestingly, in pronuclear-
stage zygotes sired by cyclophosphamide-treated males,
PARP-1 immunoreactivity is substantially elevated, not only
in the damaged paternal genome but also in the maternal
genome (Barton et al., 2007).
The genetic disruption of maternal DNA DSB repair in mice
signiﬁcantly increased the frequency of zygotes with chromo-
somal structural aberrations after paternal exposure to ionizing
radiation (Marchetti et al., 2007). Thus, DNA damage
detection and repair responses play an important role in
determining progeny outcome. The ﬁrst goal of these studies
was to elucidate the impact of a damaged male genome on
mitochondrial bioenergetics and DNA damage detection and
repair responses in the cleavage-stage embryo. The second goal
was to determine the impact of the formation of micronuclei
and of developmental delay in the cleavage-stage embryos on
their capacity to mount appropriate DNA damage responses.
MATERIALS AND METHODS
Animals, drug treatment, and embryo collection. This study was done in
accordance with the guidelines of the Canadian Council on Animal Care for the
ethical use and care of animals in science. The animal treatment protocol
(Protocol Number: 2144) was approved by the Animal Care Committee of
McGill University.
Adult male (350–400 g) and virgin female (225–250 g) Sprague Dawley rats
were purchased from Charles River Canada (St Constant, Quebec, Canada) and
housed at the Animal Resources Centre, McIntyre Medical Building, McGill
University (Montreal, Canada). Animals received food and water ad libitum
and were maintained on a 0700 h–1900 h light/dark cycle. The drug treatment
and zygote protocols previously described (Grenier et al., 2011; Trasler et al.,
1986) were followed with minor modiﬁcations. After 1 week of acclimatization,
male rats were randomly assigned to one of two treatment groups and gavaged
with saline (SAL, vehicle control) or cyclophosphamide (CAS 6055-19-2; Sigma
Chemical Co., St Louis, Missouri), 6 mg/kg/day, six times per week for
4 weeks.
On the ﬁfth week of treatment, control virgin females in proestrus (as assessed
by a vaginal wash in mid-afternoon) were caged overnight in groups of two with
either a control- or cyclophosphamide-treated male. Pregnancies were conﬁrmed
with sperm-positive vaginal smears the following morning, designated as
gestation day 0. Sperm-positive females were euthanized on day 0 at 1300 h, on
day 1 at 1000 h, and day 3 at 1000 h to collect pronuclear zygotes, 2-cell and 8-
to 16-cell embryos, respectively. Oviducts and whole uteri were isolated and
cleaned in prewarmed (37C) M2 culture medium (Sigma Chemical Co.);
pronuclear zygotes were collected from the ampullae in warm M2 medium, and
early cell cleavage embryos were ﬂushed with a 30 round gauge needle from the
infundibulum of the oviduct with 0.2 ml of warm M2 medium.
Detection of mitochondrial activity in cleavage-stage embryos. Func-
tional mitochondria were visualized in cleavage-stage embryos using
MitoTracker Green FM (catalog number M7514; Invitrogen, Burlington,
Ontario, Canada) and MitoSox Red mitochondrial superoxide indicator (catalog
number M36008; Invitrogen) probes. Embryos were incubated in vitro in
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1998). Final concentrations of 100nM for MitoTracker Green FM and of 2lM
for MitoSox Red were prepared in mR1ECM plus bovine serum albumin (BSA,
4.0 mg/ml; pH equilibrated to 7.4 with 12N HCl). This zygotic development
milieu was covered with light mineral oil to prevent evaporation and pre-
equilibrated for 3 h before incubation at 37C and 5% CO2. All solutions and
dilutions were prepared fresh the day of the experiment.
Sperm-positive females were euthanized at 1000 h on days 1 and 3 to collect
two- and eight-cell embryos in prewarmed (37C) M2 culture medium (Sigma
Chemical Co.). Embryos were ﬂushed with prewarmed (37C) M2 medium,
washed three times in prewarmed (37C) mR1ECM plus BSA, and incubated in
pre-equilibrated (37C and 5% CO2) mR1ECM plus BSA with either 100nM
MitoTracker Green FM or 2lM MitoSox Red. The time from embryo
collection to the in vitro incubation was completed in less than 7 min to
preserve embryo quality. Live in vitro embryos were incubated with
MitoTracker probes for 20 min to allow the accumulation of the probes in
active respiring mitochondria. For the immunodetection of MitoTracker
mitochondrion-selective probes, the same immunoﬂuorescence protocols were
used as previously described for the Invitrogen molecular probes under the
experimental protocol requiring ﬁxation and permeabilization after staining
with minor changes. Fixed and permeabilized embryos were incubated for 1 h
in goat blocking solution (10% goat serum, 3% BSA, and 0.1% Tween 20 in
PBS), and DNA was then stained with 4#,6-diamidino-2-phenylindole,dihy-
drochloride (DAPI), 10 lg/ml, diluted in goat blocking solution, for 20 min.
Embryos were then washed in 0.05% Tween 20 in PBS for 10 min and
mounted in 3 ll of VectaShield mounting medium (Vector Laboratories) on
a premarked pap pen slide and covered with a cover slip. Slides were then
stored at 4C and visualized with confocal microscopy within 2 days.
Immunoﬂuorescence detection of markers of DNA damage and
repair. The immunoﬂuorescence protocols used were described previously
(Grenier et al., 2010). To characterize DNA damage responses, cleavage-stage
embryos were incubated with mouse monoclonal IgG anti-cH2AX phospho-
serine 139 (clone JBW103, 1:100 dilution; catalog number 05-636, Upstate
Biotechnology, Charlottesville, VA) for 1 h at 37C, rabbit polyclonal anti-
53BP1 (1:100 dilution; catalog number NB100-304, Novus Biological,
Oakville, Ontario, Canada), or rabbit polyclonal anti-Poly (ADP-Ribose)
(PAR) (1:100 dilution; catalog number 51-8114KC, BD Bioscience Pharmin-
gen, Mississauga, Ontario, Canada) overnight at 4C in a humidiﬁed chamber.
Both primary and secondary antibodies were diluted in goat blocking solution
(10% goat serum, 3% BSA, and 0.1% Tween 20 in PBS). Zygotes were then
washed 3 3 15 min in goat blocking solution, incubated for 1 h at room
temperature with the secondary antibody, goat ﬂuorescein anti-mouse IgG
(ﬂuorescein isothiocyanate) (1:100 dilution; catalog number ab97022, Abcam,
Cambridge, MA) and goat ﬂuorescein anti-rabbit IgG (HþL) (1:200 dilution;
catalog number F1-1000, Vector Laboratories, Burlington, Ontario, Canada),
and rewashed 3 3 15 min in goat blocking solution. DNA was stained with
propidium iodide (catalog number P4864; Sigma Chemical Co.) at 10 lg/ml in
goat blocking solution for 20 min, washed in 0.05% Tween 20 in PBS for 10
min and mounted in 3 ll of VectaShield mounting medium (Vector
Laboratories) on a premarked pap pen slide and covered with a cover slip. Slides
were then stored at 4C and visualized with confocal microscopy within 2 days.
Confocal microscopy. A Zeiss LSM 510 Axiovert 100M confocal
microscope with a Plan-Apochromat 363/1.4 oil differential interference
contrast objective was used to visualize the ﬂuorescence of early cleavage-stage
embryos. The best settings for laser scanning ﬂuorescence imaging were
determined experimentally for all primary antibodies and maintained for all cell
cleavage-stage embryos. All embryos were scanned at a speed of 5–7 with an
optical slice of 0.6 lm, zoom factor equal to 1, and a pinhole setting of 96 lm.
Two scans of each optical section were compiled and averaged by the Zeiss
LSM 510 computer software to give a ﬁnal image that was 1024 3 1024 pixels
in size. The embryonic cell cleavage stage was determined by counting the
number of nuclei stained with propidium iodide or DAPI and conﬁrmed with
phase-contrast images. The presence of micronuclei as nuclear entities detached
from the main nucleus in an embryo was determined with the nuclear
propidium iodide stain or DAPI. In addition, the nuclei of blastomeres
containing micronuclei were identiﬁed using the phase-contrast images. The
cH2AX, 53BP1, PAR, and MitoSox embryo immunoﬂuorescence images from
Z-stacks were further analyzed and quantiﬁed using the Imaris image analysis
program version 7.2.3 (Bitplane, Inc., South Windsor, CT).
Quantitative Analysis. The unit of measure (N) was the number of
males; the number of embryos that are indicated below was the average
number per male. Quantiﬁcation of mitochondrial activity was done using
the MitoSox probe because the quality of the images with this probe was
superior to those obtained with MitoTracker Green; at the two- and eight-cell
stages, N ¼ 5 control males, with 28 and 41 embryos, and N ¼ 6
cyclophosphamide-treated males, with 32 and 39 embryos, respectively,
were analyzed. We analyzed all mitochondria above a set minimum threshold
intensity; the mitochondrial MitoSox intensity means and counts of all
mitochondria were compared in control- and cyclophosphamide-sired
embryos from each cleavage stage.
Immunoﬂuorescence z-stack images were used to quantify cH2AX foci per
nucleus in two- and eight-cell embryos sired by control- and cyclophospha-
mide-treated males and in the micronuclei found in embryos sired by
cyclophosphamide-treated males. For the control group, N ¼ 7 males with
64 embryos and N ¼ 10 males with 99 embryos were analyzed at the two- and
eight-cell stage, respectively, and in the cyclophosphamide-sired embryo
group, N ¼ 5 males with 56 embryos and N ¼ 7 males with 112 embryos were
analyzed at the two- and eight-cell stage, respectively. For the analysis of
53BP1 reactivity, at the pronuclear, two- and eight-cell stages in the control
group, the sample size was N ¼ 6 males with 58 embryos, N ¼ 8 males with 57
embryos, and N ¼ 7 males with 63 embryos, respectively; in the
cyclophosphamide-treated group, there were N ¼ 5 males with 39 embryos,
N ¼ 4 males with 32 embryos, and N ¼ 7 males with 68 embryos analyzed.
PAR polymers were quantiﬁed in pronuclear zygotes, two- and eight-cell
embryos: in controls, sample sizes of N ¼ 6 males with 51 embryos, N ¼ 7
males with 58 embryos, and N ¼ 8 males with 72 embryos, respectively, were
studied; in the cyclophosphamide-treated group, a sample size of N ¼ 4 males
with 45 embryos, N ¼ 5 males with 34 embryos, and N ¼ 6 males with 52
embryos was analyzed at each cleavage stage, respectively. The chromatin
structure in nuclei was compared at the two- and eight-cell stages to that in
micronuclei in cyclophosphamide-sired embryos, using N ¼ 5 and 7 males with
41 and 112 embryos for cH2AX analysis, N ¼ 4 and 6 males with 24 and 45
embryos for 53BP1, and N ¼ 5 and 6 males with 23 and 37 embryos for PAR
detection, respectively.
Measurements relevant to our hypothesis and speciﬁc for each DNA damage
response marker were analyzed using Imaris (Bitplane Inc.). In our analysis of
DNA damage with cH2AX as a marker, a nuclear surface was created from
propidium iodide staining for each embryo to measure the average nuclear and
micronuclear volume; within that surface, the total number of nuclear and
micronuclear cH2AX foci were quantiﬁed based on their volume: small foci,
0–0.29 lm
3; medium foci, 0.30–9.99 lm
3; or large foci, 10 lm
3 and above.
The data were graphed as the average number of cH2AX foci per nucleus on
each embryo collection day. To compare the DNA damage in nuclei to that in
micronuclei, the nuclear value was set to 1, and the fold difference between the
micronuclei and nuclei was examined; all values were corrected for nuclear and
micronuclear volume.
The 53BP1 and PAR average nuclear and micronuclear intensity means
were assessed relative to the DNA intensity assessed based on the nuclear
surface created from propidium iodide staining for each embryo. A second
surface was created inversely from propidium iodide staining to capture all the
cytoplasmic staining to measure the average intensity mean of 53BP1 and PAR
immunoﬂuorescence in the cytoplasm. To characterize the micronuclear
chromatin content of these DNA repair indicators, data were graphed as the
53BP1 and PAR fold difference from nuclear average intensity, comparing the
micronuclear to nuclear ratios; the 53BP1 and PAR intensity ratio are relative to
the micronuclear to nuclear DNA intensity ratio, set at 1 to correct for the
difference in DNA intensity.
DNA DAMAGE RESPONSES IN EARLY EMBRYOS 557Statistical analyses. All statistical analyses were done using Systat
(program version 10.2, Chicago, IL). Kruskal-Wallis analysis was done to
analyze for the drug effect between control- and cyclophosphamide-sired
embryos with respect to 53BP1 and PAR nuclear and cytoplasmic staining and
nuclear to cytoplasmic intensity mean ratios at each cleavage stage. Kruskal-
Wallis analysis, with Bonferroni’s correction when needed, was done to
determine a time effect between cleavage stages within a treatment group on the
53BP1 and PAR nuclear, cytoplasmic, and the nuclear to cytoplasmic intensity
mean ratios.
Mann-Whitney U-test was used to assess any differences in the number of
cH2AX foci between treatment groups at a speciﬁc cleavage stage and between
cleavage stages within a treatment group. We also used the Mann-Whitney
U-test to assess the difference in the micronuclear and nuclear chromatin
structure for cH2AX, 53BP1, and PAR immunoreactivity, as well as the
average numbers of small, medium, and large cH2AX foci per micronucleus
(corrected for volume) between cleavage stages. Values are reported either as
an average number of foci or intensity mean per embryo per replicate ± SEM or
fold difference from the nuclear number of foci or micronuclear to nuclear
DNA intensity means, set to 1 ± SEM.
RESULTS
Mitochondrial Function
Because mitochondrial activity is a useful measure of
embryo quality, we monitored their localization, numbers,
and activity within each blastomere of live cleavage-stage
embryos using MitoTracker green and MitoSox red probes
(Fig. 1). These ﬂuorescent mitochondrial probes are selective
indicators of mitochondrial function and energy production. In
addition, MitoSox red provides a measure of oxidative stress
because it indicates the presence of superoxide generated as
a byproduct of oxidative phosphorylation by a leaky mito-
chondrial electron transport chain during adenosine triphos-
phate (ATP) production. We obtained similar mitochondrial
staining patterns with both MitoTracker probes, but for
stability, reproducibility, and image quality reasons, the data
analysis was focused on the MitoSox red probe. As anticipated,
the mitochondrial staining pattern was excluded from the
nucleus in all cleavage-stage embryos. In two- to four-cell
embryos, we detected the presence of numerous bean shape
mitochondria distributed throughout each individual blasto-
mere (Fig. 1a). Furthermore, at the two-cell stage, following the
ﬁrst zygotic division, there was an even distribution of
mitochondria between blastomeres. Due to the differences in
staining patterns observed with the mitochondrial probes in
embryos collected on day 3, we analyzed the 6- to 12-cell
embryos separately from the 13- to 16-cell embryos. In 6- to
12-cell embryos, a clear compartmental distribution of
mitochondria between the nucleus and the exterior membrane
of the embryo in each blastomere was observed. In 16-cell
embryos, there was a very limited number of mitochondria in
the central blastomeres; many more mitochondria, with
a speciﬁc compartmental distribution, were found in the
external blastomeres. In addition, in 16-cell embryos, the
staining intensity of mitochondria in the central blastomeres
was extremely low compared with the high staining intensity in
mitochondria located in the external blastomeres. The pattern
of distribution of mitochondria was inﬂuenced by cell cycle
phase in all cleavage-stage embryos; mitochondria in mitotic
blastomeres lost their bean shape, were diffusely distributed in
the whole cell, and stained less intensely than those in
interphasic blastomeres (Fig. 1b). The speciﬁc localization of
mitochondria in the blastomeres of cleavage-stage embryos
may dictate the plan of cellular division with a concentration of
FIG. 1. Distribution of MitoTracker probes in cleavage-stage embryos. Immunodetection of active mitochondria by MitoSox red, indicated in red, and
MitoTracker green, depicted in green, in 2-, 8-, and 16-cell embryos. (A) Even distribution of mitochondria in blastomeres of two-cell embryos compared with the
stage-speciﬁc functional compartmentalization in eight-cell embryos. A faint low count of mitochondria was observed in central blastomeres compared with the
specialized darker distribution of mitochondria in the external blastomeres of 16-cell embryos. (B) Cell cycle–dependent mitochondrial pattern of staining, mitotic
blastomeres, circled in white, had a fainter diffuse pattern of staining, as opposed to the darker, speciﬁc distribution, in interphasic blastomeres.
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needed, thus playing a role in the cell fate decision.
Although quantiﬁcation revealed a trend toward an increase
in the mitochondrial mean intensity and a decrease in
mitochondrial count per embryo from the two- to the eight-
cell stage, these parameters were not signiﬁcantly different
between cleavage stages and treatment groups (Supplementary
ﬁg. 1a), nor did the presence of micronuclei within a cell
inﬂuence our results with MitoTracker probes at any of the cell
cleavage stages (Supplementary ﬁg. 1b).
The Characterization of cH2AX Foci in Control- and
Cyclophosphamide-Sired Cleavage-Stage Embryos
To evaluate the level of DNA damage as a consequence of
paternal exposure to cyclophosphamide in cleavage-stage
embryos, we assessed the distribution pattern of cH2AX
signals (Fig. 2). In both control- and cyclophosphamide-sired
two-cell embryos, cH2AX foci were uniformly distributed,
suggesting that these foci may be indicative of replication
stress (Fig. 2, top two rows). The staining pattern with cH2AX
in embryos collected on day 3 did not differ in 8- and 16-cell
embryos; therefore, we pooled these data and show only the
eight-cell embryos. In the eight-cell embryos, cH2AX foci
appeared to be increased in size and be more irregularly
distributed in embryos sired by cyclophosphamide-treated
males compared with controls (Fig. 2, bottom two rows).
To further characterize the population of cH2AX foci, we
subdivided them into three subgroups, based on their volumes,
and calculated the average number of each type of foci per
nucleus (Fig. 3). Control- and cyclophosphamide-sired two-cell
embryos had nearly four times as many foci as eight-cell stage
embryos; paternal exposure to cyclophosphamide had no
impact on the number of small foci at the two-cell and eight-
cell stages (Fig. 3a, left panel). Although a similar decreasing
trend, by just over 50%, in the number of medium-sized
cH2AX foci was observed between two- and eight-cell
embryos in the control group, embryos sired by cyclophos-
phamide-treated males showed a steeper decline, and the
numbers were more elevated than for control at the eight-cell
stage (p   0.05) (Fig. 3a, middle panel). In contrast to the
decrease observed in small-and medium-sized foci between
two- and eight-cell stage embryos, a signiﬁcant increase was
observed in the numbers of large cH2AX foci in both treatment
groups (p   0.05) (Fig. 3a, right panel). Few large cH2AX foci
were observed in control- and cyclophosphamide-sired two-cell
embryos. A dramatic increase in the number of large cH2AX
foci was observed in eight-cell embryos sired by cyclophos-
phamide-treated males compared with same stage control
embryos (p   0.01).The decrease in small and medium cH2AX
foci per nucleus between the two- and eight-cell embryos may
reﬂect important events in preimplantation embryo develop-
ment, such as the major and minor waves of transcription and
active DNA replication in two- and four-cell embryos; the
signiﬁcant increase in the number of large cH2AX foci in
eight-cell embryos sired by males treated with cyclophospha-
mide compared with control eight-cell embryos is likely to
reﬂect an increase in the formation of DNA DSB aggregates.
Because the amount of DNA damage, represented by
cH2AX foci, depends on the nuclear volume to compare
DNA damage in micronuclei to nuclei, we divided the number
of foci by the average nuclear volume for the nucleus and by
the average micronuclear volume for the micronucleus and
report the fold differences for the relative values in two- and
eight-cell embryos (Fig. 3b). The majority of micronuclei were
punctuated with numerous cH2AX foci. There were no
differences between the nuclei and micronuclei in the numbers
of small, medium, and large cH2AX foci in two-cell embryos
(Fig. 3b). However, in cyclophosphamide-sired eight-cell
embryos, a 1.5-fold increase in the medium cH2AX foci
(p   0.001) and a 45-fold increase in the large cH2AX foci (p
  0.001) were observed in micronuclei compared with nuclei
(Fig. 3b). Thus, medium (p   0.05) and large foci (p   0.01)
accumulate in the micronuclei of cyclophosphamide-sired
eight-cell embryos (Fig. 3c). This accumulation of damage
marks may represent an increase in the formation of DNA
DSBs or in the sites of replication errors or a failure to recruit
the appropriate DNA repair proteins.
Because micronuclei represent visible signs of DNA damage
in cyclophosphamide-sired embryos, we hypothesized that the
DNA damage response would be elevated in embryos with
micronuclei compared with those without. To test this
hypothesis, we compared the number of cH2AX foci in the
nuclei of cyclophosphamide-sired two- and eight-cell embryos
with and without micronuclei (Supplementary ﬁg. 2). Strik-
ingly, the number of cH2AX foci within each subgroup,
classiﬁed by their volume, was not dependent on the presence
and/or abundance of micronuclei in the embryos; there was
also no correlation between the nuclear DNA damage response
in individual blastomeres and the presence or absence of
micronuclei within the cell (Supplementary ﬁg. 2a). Embryos
fertilized by cyclophosphamide-exposed spermatozoa and
collected on day 3 were considered developmentally delayed
if they were at the three- and four-cell stage; normally dividing
embryos, sired by control- or cyclophosphamide-treated males,
were at the 5- to 16-cell stage at this time (Grenier et al., 2011).
Developmentally delayed cyclophosphamide-sired embryos,
with the highest incidence of micronuclei, had the same DNA
damage response proﬁle, as assessed by the numbers of
cH2AX foci, as normally dividing embryos (Supplementary
ﬁg. 2b). Thus, the presence of micronuclei did not affect the
numbers of cH2AX foci in the nuclei of cells within cleavage-
stage embryos.
53BP1 in Cleavage-Stage Embryos
Our next objective was to determine whether fertilization with
cyclophosphamide-exposed spermatozoa would affect markers
of DNA repair in cleavage-stage embryos. The localization of
53BP1 immunoreactivity in pronuclear, two- and eight-cell
DNA DAMAGE RESPONSES IN EARLY EMBRYOS 559embryos is depicted in Figure 4. The 53BP1 signal was
distributed throughout the nucleus and cytoplasm. To determine
the relative amounts of 53BP1 reactivity in these two compart-
ments, we quantiﬁed the average intensities in the nucleus and
the cytoplasm as well as the nuclear to cytoplasmic ratio in the
female and male pronuclei of the two- and eight-cell embryos
(Fig. 4b). Because intensities did not differ between the male and
female pronuclei, the average nuclear staining intensity is given
as a single value for the pronuclear-stage embryos (Fig. 4b, left
graph day 0.5, pronuclear stage embryos, PN). The staining
pattern of 53BP1 in 8- to 16-cell embryos collected on day 3 was
identical irrespective of the treatment group; therefore, we
pooled these data and show only the eight-cell embryos. The
nuclear staining tended to increase as the embryos progressed
from the pronuclear stage to the 8-cell stage in both the control-
and cyclophosphamide-sired groups (Fig. 4b, left graph); this
was accompanied by a trend toward a decrease in the
cytoplasmic 53BP1 signal (Fig. 4b, middle graph). Together,
FIG. 2. cH2AX detection of DNA DSBs in cleavage-stage embryos. The detection of DNA DSBs with cH2AX in control- and cyclophosphamide-sired two-
and eight-cell embryos. Phase-contrast images with immunodetection of cH2AX in green, nuclear propidium iodide dye in red, and merged images in yellow. The
top two rows are control- and cyclophosphamide-sired two-cell embryos, showing an even distribution of small cH2AX foci. The bottom two rows are control- and
cyclophosphamide-sired eight-cell embryos, showing nuclear region–speciﬁc large cH2AX foci in the cyclophosphamide-sired eight-cell embryos compared with
control.
560 GRENIER, ROBAIRE, AND HALESthese changes resulted in a signiﬁcant increase in the nuclear to
cytoplasmic ratio of the localization of the 53BP1 signal from
the pronuclear-stage to the 8-cell embryo in both the control-
(0.84–1.74, p   0.01) and the cyclophosphamide-treated group
(0.85–1.45, p   0.05) (Fig. 4b, right graph).
To characterize DNA repair capacity in the chromatin of
micronuclei found in cyclophosphamide-sired embryos, we
compared the intensity of 53BP1 reactivity in the micronuclei
with that in the nuclei. The 53BP1 intensities in the
micronuclei and nuclei were adjusted by the ratios of DNA
intensity because micronuclei have less DNA per equivalent
volume. In both the two- and eight-cell cyclophosphamide-sired
embryos, the micronuclear chromatin contained signiﬁcantly
more 53BP1 repair protein (1.4-fold in two-cell, p   0.05; 1.2-
fold in eight-cell, p   0.01) compared with the nuclear
chromatin (Fig. 4c). Thus, this repair protein is actively
recruited to micronuclear chromatin.
Similar to the number of cH2AX foci, 53BP1 nuclear
reactivity was not affected by the presence and/or abundance of
micronuclei in the embryos; there was also no correlation
between the nuclear DNA damage response in individual
blastomeres and the presence or absence of micronuclei within
FIG. 3. Large cH2AX foci as sites of DNA damage in cyclophosphamide-sired eight-cell embryos. The focal populations of cH2AX foci were divided into
three subgroups based on their volumes: Small foci, 0–0.29 lm
3; medium foci, 0.30–9.99 lm
3; and large foci, 10 lm
3 and above. The numbers of foci were
quantiﬁed from immunoﬂuorescence images of two- and eight-cell embryos. (A) Average numbers of foci per nucleus ± SEM are graphed; dashed lines are
control- and full lines are cyclophosphamide-sired embryos. There were signiﬁcantly more medium and large cH2AX foci in the cyclophosphamide-sired eight-cell
embryos compared with control (medium foci: control or saline [SAL] 14.77 ± 1.97 vs. cyclophosphamide-sired, CPA, 22.96 ± 3.05; large foci: SAL 0.03 ± 0.02
vs. CPA 0.21 ± 0.07). (B) Comparison of the micronuclear with nuclear chromatin content of DNA DSBs in cyclophosphamide-sired cleavage-stage embryos with
micronuclei (MN). Average number of small, medium, and large cH2AX foci per micronucleus (MN) or nucleus corrected for their volume in two- and eight-cell
embryos. Bar graphs represent the micronuclear fold difference from nuclei; micronuclear values are relative to the nuclear value set to 1 ± SEM. Gray bars
represent nuclei, and black bars are the MN. MN in cyclophosphamide-sired eight-cell embryos have 1.52- and 45.65-fold increases in the numbers of medium and
large cH2AX foci relative to their nuclear counterparts. (C) Changes in the numbers of cH2AX foci in MN of cyclophosphamide-sired early cleavage-stage
embryos. Line graphs represent the average number of cH2AX foci, within their respective groups, per MN corrected for micronuclear volume ± SEM. Illustrated
in the ﬁgure legend, small, medium, and large dashed lines represent the sizes of the cH2AX foci, respectively. MN signiﬁcantly accumulated medium (0.009–
0.024) and large (0.000–0.003) cH2AX foci in cyclophosphamide-sired two- and eight-cell embryos. Mann-Whitney U-test was performed with N ¼ 7, 10 males
with 64, 99 embryos in control and N ¼ 5, 7 males with 41, 112 embryos in cyclophosphamide-sired in two- and eight-cell embryos, respectively. *p   0.05, **p
  0.01, and ***p   0.001.
DNA DAMAGE RESPONSES IN EARLY EMBRYOS 561the cell (Supplementary ﬁg. 3a). In addition, developmentally
delayed cyclophosphamide-sired embryos had the same DNA
damage response proﬁle, assessed by the nuclear reactivity with
53BP1, as normally dividing embryos (Supplementary ﬁg. 3b).
Poly(ADP-ribose) Polymers in Cleavage-Stage Embryos
The immunoreactive poly(ADP-ribose) polymers (PAR),
representing the product of poly(ADP-ribose) polymerase
activities, in pronuclear two- and eight-cell embryos are
shown in Figure 5a. The PAR signal was consistently more
intense in the nucleus compared with the cytoplasm. As for
53BP1, the PAR immunoreactivity did not differ between the
male and female pronuclei of pronuclear-stage embryos. The
staining pattern also did not differ between 8- and 16-cell
embryos irrespective of the treatment group. Neither
developmental stage nor treatment signiﬁcantly affected the
intensity of the PAR signal in the cytoplasm or the nuclear to
cytoplasmic ratio (Fig. 5b, middle and right graph). In
contrast, embryos sired by cyclophosphamide-treated males
displayed a dramatic decrease in PAR nuclear mean intensity
at the eight-cell cleavage stage (p   0.01) (Fig. 5b,l e f t
graph). In both the two- and eight-cell cyclophosphamide-
sired embryos, the micronuclear chromatin contained signif-
icantly more PAR polymers (1.5-fold in two-cell, p   0.01;
1.3-fold in eight-cell, p   0.01) compared with the nuclear
chromatin (Fig. 5c).
FIG. 4. 53BP1 reactivity in cleavage-stage embryos. (A) 53BP1 reactivity in pronuclear zygotes, two- and eight-cell embryos from control- and
cyclophosphamide-sired groups. 53BP1 is in green, nuclear propidium iodide dye in red, and merged images in yellow. The top row images are control embryos,
whereas bottom row images are cyclophosphamide-sired embryos at all embryonic cleavage stages. Arrows point toward the female (F) and male (M) pronuclei
(PN) and the micronuclei (MN) as circled in white. (B) Immunoﬂuorescence images are quantiﬁed as the 53BP1 intensity in the nucleus, the cytoplasm and the
ratio of the nucleus to cytoplasm as means ± SEM. Dashed lines represent control- and full lines cyclophosphamide-sired embryos. Independent of treatment
group, there was a cytoplasmic to nuclear shift in the localization of 53BP1 repair protein as the cleavage-stage embryo divided (SAL PN 0.84 ± 0.06; SAL 8c 1.74
± 0.12; CPA PN 0.85 ± 0.09; and CPA 8c 1.45 ± 0.17). C. Comparison of the micronuclear with nuclear chromatin content of 53BP1 repair protein in
cyclophosphamide-sired cleavage-stage embryos with MN. Bar graphs illustrate the 53BP1 reactivity fold difference between their micronuclear and nuclear
counterparts, comparing the relative micronuclear with nuclear average 53BP1 intensity mean ratios with DNA intensity ratios, both set to 1 ± SEM. Gray bars are
the DNA ratios, and black bars are the 53BP1 intensity ratios. In two- and eight-cell embryos, MN are enriched with 53BP1 repair proteins (1.43- and 1.20-fold
increases in cyclophosphamide-sired two- and eight-cell embryos), relative to the nuclei. Kruskal-Wallis analysis plus Bonferroni’s correction, when needed, was
performed with N ¼ 6–8 males with 57–63 embryos in the control group and N ¼ 4–7 males with 32–68 embryos in the cyclophosphamide-sired group.
Comparisons of the intensity means using the Mann-Whitney U-test was performed with N ¼ 4–6 males with 24–45 embryos for the micronuclei to nuclei
comparison. *p   0.05, **p   0.01, and ***p   0.001.
562 GRENIER, ROBAIRE, AND HALESOnce again, the nuclear signal of PAR polymers was not
affected by the presence and/or abundance of micronuclei in
the two- and eight-cell cyclophosphamide-sired embryos
(Supplementary ﬁg. 4a) or, in eight-cell cyclophosphamide-
sired embryos, by a delay in the rate of development
(Supplementary fig. 4b).
DISCUSSION
Paternal exposure to cyclophosphamide did not affect
mitochondrial functional compartmentalization or bioenergetic
activities in cleavage-stage embryos. However, markers of the
DNA damage detection and repair responses were affected. In
the eight-cell embryo, paternal cyclophosphamide exposure led
to the selective formation of medium and large cH2AX foci
and a decrease in nuclear PAR polymers in the absence of
an effect on 53BP1 reactivity. All three DNA damage response
indicators were enriched in micronuclei. However, cells with
micronuclei had a similar DNA damage response to those
without micronuclei.
The specialized localization of mitochondria during embry-
onic development is hypothesized to play a critical role in the
regulation of energy production and consumption as well as
roles in calcium homeostasis, cytoplasmic redox state, and
FIG. 5. Poly(ADP-ribose) (PAR) polymer reactivity in cleavage-stage embryos. (A) Poly(ADP-ribose) polymer (PAR) reactivity in pronuclear zygotes, two-
and eight-cell control- and cyclophosphamide-sired embryos. PAR is in green, nuclear propidium iodide dye in red, and merged images in yellow. The top row
images are control embryos, whereas the bottom row images are cyclophosphamide-sired embryos at all embryonic cleavage stages. Arrows point toward the
female (F) and male (M) pronucleus (PN) and micronuclei (MN) are circled in white. (B) Immunoﬂuorescence images are quantiﬁed into nuclear, cytoplasmic, and
nuclear to cytoplasmic ratios of PAR intensity means ± SEM. Dashed lines are control- and full lines are cyclophosphamide-sired embryos. There is a signiﬁcant
decrease in the nuclear PAR reactivity in cyclophosphamide-sired embryos at the eight-cell stage compared with control embryos (SAL 8c is 116.68 ± 7.67 vs.
cyclophosphamide 8c at 74.17 ± 11.19). (C) Comparison of the micronuclear with nuclear chromatin content of PAR polymer reactivity in cyclophosphamide-sired
cleavage-stage embryos with MN. Bar graphs illustrate the micronuclear fold difference in PAR reactivity from their nuclear counterpart by comparing the relative
micronuclear with nuclear average PAR intensity mean ratios with the DNA intensity ratios, both set to 1 ± SEM. Gray bars are the DNA ratios, and black bars are
the PAR ratios. In two- and eight-cell embryos, MN are enriched with PAR polymers (1.49- and 1.30-fold increase in cyclophosphamide-sired two- and eight-cell
embryos) relative to the nuclei. Kruskal-Wallis analysis plus Bonferroni’s correction, when necessary, was performed, N ¼ 6–8 males with 51–72 embryos in
control and N ¼ 4–6 males with 34–52 embryos in the cyclophosphamide-sired group for the PAR localization and intensity means. The Mann-Whitney U-test was
performed with N ¼ 5–6 males with 23–37 embryos for the micronuclear to nuclear comparison. *p   0.05, **p   0.01, and ***p   0.001.
DNA DAMAGE RESPONSES IN EARLY EMBRYOS 563signal transduction (van Blerkom, 2011). As observed for
human and mouse embryos (van Blerkom, 2011), the staining
intensities and distribution patterns of MitoTracker green
and MitoSox red in early embryos display embryonic de-
velopmental stage and compartmental speciﬁcity. In eight-cell
embryos, the localization of mitochondria between the nucleus
and the plasma membrane on a speciﬁc side of the embryo may
determine the plane of the next cycle of division by
concentrating the energy necessary to allow normal develop-
mental progression. In 16-cell embryos, we observed a very
faint diffuse type of staining for mitochondria in central
blastomeres, as opposed to a stronger and compartmentalized
type of staining in blastomeres surrounding the embryo. These
stage- and space-speciﬁc mitochondrial distributions closely
resemble the differences in mitochondrial structure and number
between the two cell types in the future blastocyst; inner cell
mass cells are hypopolarized, almost metabolically quiescent,
as opposed to the trophectoderm cells that are hyperpolarized at
the basal aspect of the plasma membrane and produce almost
80% of the net ATP (Houghton, 2006; van Blerkom et al.,
2002). Because the initial pool of mitochondria in the oocyte is
not replenished until after blastocyst implantation and
mitochondria are evenly divided between blastomeres, there
was a tendency for the mitochondrial count per blastomere to
decrease as the embryos progressed through cleavage stages
(Larsson et al., 1998).
If fertilization with cyclophosphamide-exposed spermatozoa
had increased energy demand in the embryo due to the
requirement for an enhanced DNA repair response, we might
have anticipated a decrease in energy stores. However,
fertilization with cyclophosphamide-exposed spermatozoa did
not have any impact on the distribution or staining intensity of
the mitochondrial MitoTracker Green or MitoSox Red probes,
indicating that the general energy stores and intracellular redox
status of cleavage-stage embryos were unaltered. Thus, the
MitoSox and MitoTracker probes were valuable tools to show
that embryos with damaged DNA may be otherwise normal, at
least in terms of energy stores. It is clear that the mitochondrial
energetic status observed in early cleavage-stage embryos is
sufﬁcient to allow the progression of embryos during pre-
implantation development even in the presence of heavy DNA
damage. Moreover, these results indicate that mitochondrial
function is not, by itself, sufﬁcient to predict development
competence, especially for male-mediated DNA damage such
as that induced by cyclophosphamide.
In cleavage-stage embryos, we observed the greatest level of
H2AX phosphorylation at the two-cell stage, coincident with
major chromatin reorganization during DNA replication and
zygotic genome activation; the level of staining was signiﬁ-
cantly reduced at the eight-cell stage. H2AX is phosphorylated
in response to DNA DSBs that arise from exposure to
exogenous chemicals, radiation or reactive oxygen species
that induce replication stress (Ismail et al., 2007; Rogakou
et al., 1998), as well as in response to physiological processes,
such as DNA replication errors, chromatin remodeling during
protamine to histone transition in pre-pronuclear zygotes, and
meiosis (Grenier et al.,2 0 1 0 ). The small cH2AX foci observed
support a role for the phosphorylation of H2AX in the control
of chromatin structural reorganization (Barton et al., 2007) and
proper developmental progression of rapidly dividing stressed
embryos (Ziegler-Birling et al., 2009) in the absence of
induced DNA damage. The signiﬁcant increase in medium
cH2AX foci in cyclophosphamide-sired eight-cell embryos,
compared with controls, suggests that these medium foci may
be important in the recognition of DNA damage. The large
cH2AX foci visualized in eight-cell embryos sired by
cyclophosphamide-treated males are likely to represent the
accumulation of cH2AX at hot spots of DNA damage, perhaps
as a consequence of the failure to complete the repair process in
early embryos (Barton et al.,2 0 0 7 ; Grenier et al., 2010).
Earlier studies have reported a similar phenomenon in a murine
model; paternal exposure to radiation impaired blastocyst
development due to inappropriate repair during the ﬁrst cell
cycle division and led to de novo mutations (Derijck et al.,
2008). Interestingly, the presence of micronuclei in early
embryos did not inﬂuence the quantity or nature of the cH2AX
foci in the nuclei of these embryos.
DNA damage repair capacity in cleavage-stage embryos was
assessed in the pronuclear zygote, two- and eight-cell embryo
with two markers of DNA repair, 53BP1 and poly(ADP-ribose)
polymers, that are known to be recruited to the sites of DNA
DSBs detected by cH2AX. It is not likely that the 53BP1
immunoreactivity is strongly colocalized with cH2AX in these
embryos because a faint diffuse and homogenous pattern of
53BP1 distribution was observed in both the nuclear and
cytoplasmic compartments throughout the cell cleavage stages
studied. In addition, 53BP1 protein expression was unaffected
by the presence of a damaged male genome. Similar ﬁndings
were reported previously in a damage free mouse embryonic
model in which 53BP1 protein localization changed upon
blastocyst formation. The failure of 53BP1 and cH2AX to
colocalize in the embryo (Ziegler-Birling et al., 2009)
reinforces the notion that the high levels of H2AX phosphor-
ylation may be linked to chromatin remodeling in the early
embryo rather than directly to a DNA damage response
(Ziegler-Birling et al., 2009). The developmental signiﬁcance
of the nuclear retention of 53BP1 as a partial mediator of p53
activity in regulating cell cycle checkpoints, allowing the
progression of cell cycle division of cleavage-stage embryos,
has been established previously (Fernandez-Capetillo et al.,
2003).
A decrease in nuclear poly(ADP-ribose) polymers was
observed in eight-cell embryos sired by cyclophosphamide-
exposed spermatozoa. The presence of micronuclei did not
inﬂuence the amount of poly(ADP-ribose) polymers in the
nucleus. In general, a decrease in poly(ADP-ribose) polymers
is suggestive of a decrease in the poly(ADP-ribosyl)ation of
histones and/or PARP-1 (Zhou et al.,2 0 1 0 ). This may result in
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potential DNA damage repair proteins to DNA (Zhou et al.,
2010); however, examination of the gross nuclear morphology
of cyclophosphamide-sired eight-cell embryos did not reveal
any apparent increase in condensed chromatin. Numerous
scenarios could lead to a decrease in poly(ADP-ribosyl)ation
in early embryos; these include NADH energy depletion,
reducing PARP-1 activity, an increase in PARP-1 activity,
leading to auto-poly(ADP-ribosyl)ation of PARP-1 and its
inactivation, or an increase in PARG catalytic activity,
removing poly(ADP-ribose) polymers. Previously, we reported
that paternal exposure to cyclophosphamide led to an increase
in PARP-1 immunoreactivity in both male and female
pronuclei (Barton et al., 2007). Our data show that there is
no drug treatment effect on the level of poly(ADP-ribosyl)ation
in pronuclear or two-cell embryos, suggesting that the increase
in PARP-1 immunoreactivity may be accompanied by an
increase in PARG catalytic activity, dampening the repair
capacity of cleavage-stage embryos. The reduced PARP-1
activity observed in eight-cell embryos was not associated with
a decrease in mitochondrial energy status, as assessed with the
MitoTracker probes; therefore, the reduction in PAR polymers
does not appear to be due to a decrease in energy stores in the
embryo.
Energy depletion as a result of PARP-induced NADH
depletion may contribute to the delay in cell cycle progression
seen at the eight-cell stage (Grenier et al., 2011). Develop-
mental arrest was reported in pronuclear-stage mouse embryos
treated with a PARP inhibitor (Osada et al., 2010). It is clear
that the proper functioning of the complex poly(ADP-
ribosyl)ation system is necessary for the early stages of mouse
embryogenesis (Osada et al., 2010).
Micronuclei are a readily identiﬁable mark of DNA damage
in the paternal genome in embryos sired by cyclophospha-
mide-treated males. In two- and eight-cell embryos, both
53BP1 and poly(ADP-ribose) polymers were enriched in
chromatin in the micronuclei compared with the nuclei; this
enrichment was observed in the absence of any increase in
cH2AX foci, tagging DNA DSBs. These ﬁndings suggest that
there may be a cH2AX-independent mechanism of recruit-
ment of 53BP1 and poly(ADP-ribose) polymers in micro-
nuclei at the two-cell stage. By the eight-cell stage, a marked
accumulation of medium and large cH2AX foci was observed
in micronuclei; this occurred in the absence of an increase in
the intensity of the staining for 53BP1 or poly(ADP-ribose)
polymers in comparison with the two-cell embryos. The
accumulation of cH2AX foci in the micronuclei of eight-cell
embryos may indicate the failure of DNA repair processes to
resolve DNA DSBs (Celeste et al., 2003). Micronuclei may
gradually lose functionality as the embryo progresses from
two-cells to eight-cells; indeed, we reported previously that
the incorporation of EdU (5-ethynyl-2#-deoxyuridine) into
DNA was decreased in micronuclei at the eight-cell stage
(Grenier et al.,2 0 1 1 ).
In summary, we have demonstrated that fertilization by
sperm from cyclophosphamide-treated male rats produces
a conceptus with a heavily damaged paternal genome. The
damaged paternal genome triggers both a cH2AX-dependent
and a cH2AX-independent DNA damage response with respect
to micronuclear formation, within the same cells. The two-cell
embryo is capable of mounting a DNA damage response
because there is a recruitment of 53BP1 and an increase in
poly(ADP-ribose) polymers in micronuclei. However, the
DNA repair response is not adequate to prevent the
accumulation of medium and large cH2AX foci in micronuclei
by the eight-cell stage. The accumulation of DNA damage and
the inability of the embryo to adequately repair the paternal
genome are likely to contribute to the elevated pre- and
postimplantation death observed as a consequence of paternal
cyclophosphamide exposure.
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